Salt AI

Salt AI is a technology company that specializes in AI workflow platforms, focusing on life sciences and other sectors. Founded in 2023 by industry veterans Aber Whitcomb and Jim Benedetto, the company aims to enhance advancements in these fields through reliable and transparent AI solutions. The concept for Salt AI originated from AI experiments in game development. The company offers a model-agnostic platform that enables users to integrate and optimize various AI models for specific tasks. This platform promotes collaboration among scientists, researchers, and non-engineers by providing visual transparency and a modular structure. Users can create custom AI workflows tailored to their needs, particularly in drug discovery, by combining different models. Salt AI has partnered with the Ellison Medical Institute to develop a drug discovery platform, showcasing its commitment to supporting innovative therapeutic developments. Salt AI's platform is designed for efficiency, optimizing AI models for speed and reducing computational costs, making it a valuable tool in the life sciences sector.